Yukinari Kato

14.8k total citations
420 papers, 10.6k citations indexed

About

Yukinari Kato is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yukinari Kato has authored 420 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Oncology, 149 papers in Molecular Biology and 131 papers in Immunology. Recurrent topics in Yukinari Kato's work include Lymphatic System and Diseases (124 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Glycosylation and Glycoproteins Research (88 papers). Yukinari Kato is often cited by papers focused on Lymphatic System and Diseases (124 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Glycosylation and Glycoproteins Research (88 papers). Yukinari Kato collaborates with scholars based in Japan, United States and Thailand. Yukinari Kato's co-authors include Mika K. Kaneko, Satoshi Ogasawara, Shinji Yamada, Naoya Fujita, Takashi Tsuruo, Takuro Nakamura, Motoki Osawa, Hisashi Narimatsu, Kazuhiko Mishima and Akiko Kunita and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yukinari Kato

409 papers receiving 10.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukinari Kato Japan 50 6.2k 3.9k 2.6k 2.5k 1.5k 420 10.6k
Scott E. Strome United States 48 6.9k 1.1× 2.1k 0.5× 1.4k 0.5× 6.1k 2.5× 746 0.5× 144 11.5k
Alan L. Epstein United States 51 2.9k 0.5× 2.9k 0.7× 773 0.3× 3.2k 1.3× 2.2k 1.4× 204 9.1k
Pilar Garin‐Chesa United States 48 4.7k 0.8× 3.9k 1.0× 962 0.4× 827 0.3× 855 0.6× 100 9.2k
Gert Riethmüller Germany 47 5.1k 0.8× 3.1k 0.8× 633 0.2× 3.3k 1.4× 1.9k 1.2× 112 10.4k
Yutaka Kawakami Japan 62 5.5k 0.9× 6.0k 1.5× 577 0.2× 9.0k 3.6× 1.3k 0.8× 263 15.1k
Herbert A. Weich Germany 52 3.2k 0.5× 7.7k 2.0× 1.1k 0.4× 1.1k 0.5× 649 0.4× 114 11.9k
Michele W.L. Teng Australia 56 9.2k 1.5× 3.6k 0.9× 833 0.3× 8.3k 3.4× 588 0.4× 95 15.0k
Wolfgang J. Rettig United States 41 4.7k 0.8× 4.8k 1.2× 779 0.3× 1.0k 0.4× 845 0.6× 75 9.7k
Denise Crowley United States 37 5.5k 0.9× 8.8k 2.2× 1.3k 0.5× 1.4k 0.6× 298 0.2× 48 14.0k
Adrian Merlo Switzerland 46 2.8k 0.4× 5.8k 1.5× 758 0.3× 578 0.2× 883 0.6× 89 9.4k

Countries citing papers authored by Yukinari Kato

Since Specialization
Citations

This map shows the geographic impact of Yukinari Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukinari Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukinari Kato more than expected).

Fields of papers citing papers by Yukinari Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukinari Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukinari Kato. The network helps show where Yukinari Kato may publish in the future.

Co-authorship network of co-authors of Yukinari Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yukinari Kato. A scholar is included among the top collaborators of Yukinari Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukinari Kato. Yukinari Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lasota, Jerzy, Maciej Kaczorowski, Małgorzata Chłopek, et al.. (2025). An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy. Human Pathology. 155. 105717–105717. 1 indexed citations
2.
Suzuki, Hiroyuki, et al.. (2025). Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry. Biochemistry and Biophysics Reports. 43. 102138–102138.
3.
Tanaka, Tomohiro, Yu Kaneko, Hirotaka Yamamoto, et al.. (2025). Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry. Biochemistry and Biophysics Reports. 41. 101960–101960. 2 indexed citations
4.
Kaneko, Mika K., Hiroyuki Suzuki, Tomokazu Ohishi, et al.. (2025). Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. International Journal of Molecular Sciences. 26(3). 1079–1079. 2 indexed citations
5.
Arimori, Takao, Emiko Mihara, Hiroyuki Suzuki, et al.. (2024). Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies. Structure. 32(5). 536–549.e5. 11 indexed citations
6.
Suzuki, Hiroyuki, Tomokazu Ohishi, Takuro Nakamura, et al.. (2024). Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology Reports. 52(5). 8 indexed citations
7.
Suzuki, Hiroyuki, et al.. (2023). A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences. 24(9). 8411–8411. 7 indexed citations
8.
Konnai, Satoru, Tomohiro Okagawa, Naoya Maekawa, et al.. (2023). Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in sheep. Veterinary Immunology and Immunopathology. 261. 110609–110609. 1 indexed citations
9.
Watanabe, Satoshi, Norimichi Nomura, Kehong Liu, et al.. (2023). Cryo-EM structures of human zinc transporter ZnT7 reveal the mechanism of Zn2+ uptake into the Golgi apparatus. Nature Communications. 14(1). 4770–4770. 21 indexed citations
10.
Okagawa, Tomohiro, Satoru Konnai, Hayato Nakamura, et al.. (2023). Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves. Vaccines. 11(3). 559–559.
11.
Maekawa, Naoya, Satoru Konnai, Yamato Sajiki, et al.. (2022). Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy. Scientific Reports. 12(1). 9265–9265. 12 indexed citations
12.
Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K. Kaneko, & Yukinari Kato. (2022). Identification of the Binding Epitope of an Anti-mouse CCR4 Monoclonal Antibody, C 4 Mab-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(4). 214–220. 2 indexed citations
13.
Asano, Teizo, Tomokazu Ohishi, Junko Takei, et al.. (2021). Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncology Reports. 46(2). 22 indexed citations
14.
Sayama, Yusuke, Masato Sano, Mika K. Kaneko, & Yukinari Kato. (2020). Epitope Analysis of an Anti-Whale Podoplanin Monoclonal Antibody, PMab-237, Using Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(1). 17–22. 10 indexed citations
15.
Sano, Masato, Mika K. Kaneko, & Yukinari Kato. (2019). Epitope Mapping of Monoclonal Antibody PMab-233 Against Tasmanian Devil Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(6). 261–265. 13 indexed citations
16.
Takei, Junko, Yoshikazu Furusawa, Shinji Yamada, et al.. (2019). PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(4). 171–174. 13 indexed citations
17.
Takei, Junko, Shinji Yamada, Satoru Konnai, et al.. (2019). PMab-241 Specifically Detects Bear Podoplanin of Lymphatic Endothelial Cells in the Lung of Brown Bear. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(6). 282–284. 8 indexed citations
18.
Sayama, Yusuke, Masato Sano, Yoshikazu Furusawa, Mika K. Kaneko, & Yukinari Kato. (2019). Epitope Mapping of PMab-225 an Anti-Alpaca Podoplanin Monoclonal Antibody Using Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(6). 255–260. 14 indexed citations
19.
Yamada, Shinji, Shunsuke Itai, Takuro Nakamura, et al.. (2018). Monoclonal Antibody L 1 Mab-13 Detected Human PD-L1 in Lung Cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(2). 110–115. 45 indexed citations
20.
Yamada, Shinji, Shunsuke Itai, Mika K. Kaneko, & Yukinari Kato. (2018). Anti-Podocalyxin Monoclonal Antibody 47-mG 2a Detects Lung Cancers by Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(2). 91–94. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott E. Strome Breakdown of academic impact, for papers by Alan L. Epstein Breakdown of academic impact, for papers by Pilar Garin‐Chesa Breakdown of academic impact, for papers by Gert Riethmüller Breakdown of academic impact, for papers by Yutaka Kawakami Breakdown of academic impact, for papers by Herbert A. Weich Breakdown of academic impact, for papers by Michele W.L. Teng Breakdown of academic impact, for papers by Wolfgang J. Rettig Breakdown of academic impact, for papers by Denise Crowley Breakdown of academic impact, for papers by Adrian Merlo
Rankless by CCL
2026